Cbd Life Sciences Stock Performance
| CBDL Stock | USD 0.0005 0.0001 16.67% |
Cbd Life holds a performance score of 4 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -3.61, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Cbd Life are expected to decrease by larger amounts. On the other hand, during market turmoil, Cbd Life is expected to outperform it. Use Cbd Life treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to analyze future returns on Cbd Life.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cbd Life Sciences are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain fundamental indicators, Cbd Life disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Total Cashflows From Investing Activities | -185.8 K |
Cbd |
Cbd Life Relative Risk vs. Return Landscape
If you would invest 0.08 in Cbd Life Sciences on August 26, 2024 and sell it today you would lose (0.03) from holding Cbd Life Sciences or give up 37.5% of portfolio value over 90 days. Cbd Life Sciences is currently generating 1.4077% in daily expected returns and assumes 23.4767% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Cbd, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cbd Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cbd Life's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Cbd Life Sciences, and traders can use it to determine the average amount a Cbd Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.06
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | CBDL | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 23.48 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.41 actual daily | 28 72% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Cbd Life is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cbd Life by adding it to a well-diversified portfolio.
Cbd Life Fundamentals Growth
Cbd Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Cbd Life, and Cbd Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cbd Pink Sheet performance.
| Return On Equity | -3.89 | |||
| Return On Asset | 0.0025 | |||
| Operating Margin | (23.29) % | |||
| Current Valuation | 51.93 K | |||
| Shares Outstanding | 3.58 K | |||
| Price To Sales | 0.26 X | |||
| Revenue | 138.19 K | |||
| EBITDA | (608.24 K) | |||
| Cash And Equivalents | 303.09 K | |||
| Debt To Equity | 0.20 % | |||
| Cash Flow From Operations | (6.29 M) | |||
About Cbd Life Performance
By examining Cbd Life's fundamental ratios, stakeholders can obtain critical insights into Cbd Life's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Cbd Life is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. Cbd Life operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.Things to note about Cbd Life Sciences performance evaluation
Checking the ongoing alerts about Cbd Life for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Cbd Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cbd Life Sciences is way too risky over 90 days horizon | |
| Cbd Life Sciences has some characteristics of a very speculative penny stock | |
| Cbd Life Sciences appears to be risky and price may revert if volatility continues | |
| Cbd Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 138.19 K. Net Loss for the year was (6.14 M) with profit before overhead, payroll, taxes, and interest of 27.43 K. | |
| Cbd Life Sciences currently holds about 303.09 K in cash with (6.29 M) of positive cash flow from operations. |
- Analyzing Cbd Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cbd Life's stock is overvalued or undervalued compared to its peers.
- Examining Cbd Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cbd Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cbd Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cbd Life's pink sheet. These opinions can provide insight into Cbd Life's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Cbd Pink Sheet
Cbd Life financial ratios help investors to determine whether Cbd Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cbd with respect to the benefits of owning Cbd Life security.